Research & Insights
September 25, 2024
Lazard Global Biopharmaceutical Leaders Study 2024
Biopharmaceutical and biotech investors concluded the summer of 2024 facing ongoing uncertainty.
Lazard Interim Secondary Market Report 2024
Lazard Interim Secondary Market Report 2024
COVID-19 Inflation Disruptions and Supply Shock: Insights from Lazard and the Brookings Institution
COVID-19 Inflation Disruptions and Supply Shock: Insights from Lazard and the Brookings Institution